VenomAid Diagnostics is a company that provides clinically rapid diagnostic tests for snakebite envenoming.
VenomAid Diagnostics has raised $800K in total funding. The most recent round was Seed. The last funding was announced in January 2024.
VenomAid Diagnostics's investors include Novo Nordisk Foundation, Good Ventures.
VenomAid Diagnostics is headquartered in Kongens Lyngby, Denmark.
VenomAid Diagnostics is a company that provides clinically rapid diagnostic tests for snakebite envenoming.
VenomAid Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VenomAid Diagnostics — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/venomaid-diagnostics. Accessed August 14, 2026.
VCBacked. (2024). VenomAid Diagnostics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/venomaid-diagnostics
{{cite web |title=VenomAid Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/venomaid-diagnostics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated